Last $2.31 USD
Change Today -0.10 / -4.15%
Volume 31.8K
GNVC On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark J. Mendel Ph.D.

Former Board Observer, GenVec, Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 3 different industries.

See Board Relationships
----

Background*

Dr. Mark J. Mendel, Ph.D. serves as a Managing Director and Founder of RiverVest Venture Partners. He brings venture capital, medical research, and product development experience to RiverVest. He is a Founder and Chairman of the Board at Auxeris Therapeutics, Inc., a member of the Board of Directors of Cydex, Inc. and a Board Observer at Xcyte Therapies, Inc., all RiverVest portfolio companies. Previously, Dr. Mendel was a Vice President at Arch Venture Partners. While ...

Read Full Background

Corporate Headquarters*

910 Clopper Road
Gaithersburg, Maryland 20878

United States

Phone: 240-632-0740
Fax: 240-632-0735

Board Members Memberships*

Director
Former Board Observer
Board Observer
Former Director
Managing Director and Founder
Director
Managing Director
Board Observer
Managing Director

Education*

BS
Cornell University
MS
The University of Pennsylvania
PhD
The University of Pennsylvania

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNVC:US $2.31 USD -0.10

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
$557.0K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Daniel J. O’Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$312.5K
Jonathan J. Lewis M.D., Ph.D.Chief Executive Officer and Director
ZIOPHARM Oncology, Inc.
$600.0K
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$334.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENVEC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.